Recombinant human hexamer-dominant IgM monoclonal antibody to ganglioside GM3 for treatment of melanoma

Y Azuma, Y Ishikawa, S Kawai, T Tsunenari… - Clinical cancer …, 2007 - AACR
Purpose: L612, a human IgM monoclonal antibody produced by an EBV-transformed human
B-cell line, binds to ganglioside GM3 and kills GM3-positive human melanoma cells in the …
被引用次数：57 相关文章

[引用][C] Recombinant human hexamer-dominant IgM monoclonal antibody to ganglioside GM3 for treatment of melanoma

Y AZUMA, Y ISHIKAWA, M TSUCHIYA… - Clinical cancer …, 2007 - pascal-francis.inist.fr
Recombinant human hexamer-dominant IgM monoclonal antibody to ganglioside GM3 for
treatment of melanoma CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …

Recombinant Human Hexamer-Dominant IgM Monoclonal Antibody to Ganglioside GM3 for Treatment of Melanoma

Y Azuma, Y Ishikawa, S Kawai, T Tsunenari… - Clinical Cancer …, 2007 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Purpose: L612, a human IgM monoclonal
antibody produced by an EBV-transformed human B-cell line, binds to ganglioside GM3 and …

Recombinant human hexamer-dominant IgM monoclonal antibody to ganglioside GM3 for treatment of melanoma

Y Azuma, Y Ishikawa, S Kawai… - … : an official journal …, 2007 - pubmed.ncbi.nlm.nih.gov
Purpose L612, a human IgM monoclonal antibody produced by an EBV-transformed human
B-cell line, binds to ganglioside GM3 and kills GM3-positive human melanoma cells in the …

Recombinant human hexamer-dominant IgM monoclonal antibody to ganglioside GM3 for treatment of melanoma.

Y Azuma, Y Ishikawa, S Kawai, T Tsunenari… - … Cancer Research: an …, 2007 - europepmc.org
Purpose L612, a human IgM monoclonal antibody produced by an EBV-transformed human
B-cell line, binds to ganglioside GM3 and kills GM3-positive human melanoma cells in the …

[引用][C] Recombinant human hexamer-dominant IgM monoclonal antibody to ganglioside GM3 for treatment of melanoma

Y AZUMA, Y ISHIKAWA… - Clinical …, 2007 - American Association for Cancer …